FHAM
CLVS

Folger Hill Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Folger Hill Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-101,002
Closed -$9.46M – 308
2017
Q2 		$9.46M Buy
101,002
+45,002
+80% +$2.75M 0.85% 40
2017
Q1 		$3.57M Buy
+56,000
New +$3.4M 0.29% 107
2016
Q3 		– Sell
-143,300
Closed -$1.97M – 291
2016
Q2 		$1.97M Buy
+143,300
New +$2.09M 0.15% 133

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PointState Capital
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Folger Hill Asset Management's CLVS Position: Q3 2017 in Review

Folger Hill Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2017, closing a stake of 101,002 shares — an estimated $9.46M sold.

Folger Hill Asset Management first reported a position in CLVS in Q2 2016 and held it in 3 quarters. The position peaked at $9.46M in Q2 2017. 255 funds tracked by Wall St. Rank hold CLVS as of Q3 2017.

  • Folger Hill Asset Management reported no remaining Clovis Oncology, Inc. position as of Q3 2017 after selling out during the quarter.
  • Folger Hill Asset Management sold 101,002 Clovis Oncology, Inc. shares in Q3 2017, an estimated $9.46M.
  • Folger Hill Asset Management first reported a position in Clovis Oncology, Inc. in Q2 2016 and held it in 3 quarters.
  • Folger Hill Asset Management's Clovis Oncology, Inc. position peaked at $9.46M in Q2 2017.
  • 255 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2017.

Based on Folger Hill Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.